1. Kuo, Shou-Jen, Chien, Su-Yu, Lin, Che, Tsai, Hsiu-Ting, Chen, Dar-Ren. . Significant elevation of CLDN16 and HAPLN3 gene expression in human breast cancer. In Oncology reports, 24, 759-66. doi:. https://pubmed.ncbi.nlm.nih.gov/20664984/
2. Ding, Yi, Xiong, Shida, Chen, Xinpeng, Fan, Jiawen, Guo, Ju. 2022. HAPLN3 inhibits apoptosis and promotes EMT of clear cell renal cell carcinoma via ERK and Bcl-2 signal pathways. In Journal of cancer research and clinical oncology, 149, 79-90. doi:10.1007/s00432-022-04421-3. https://pubmed.ncbi.nlm.nih.gov/36374334/
3. Xu, Jun, Zou, Zhengxing, Liu, Wanyang, Wang, Yue, Duan, Lian. 2024. HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K. In European journal of neurology, 31, e16473. doi:10.1111/ene.16473. https://pubmed.ncbi.nlm.nih.gov/39315749/
4. Chen, Xiaohang, Li, Gaochi, Zhang, Jian, Wei, Fengxiang, Xiong, Fu. 2024. The temporal protein signature analyses of developing human deciduous molar tooth germ. In Proteomics, 24, e2300396. doi:10.1002/pmic.202300396. https://pubmed.ncbi.nlm.nih.gov/38522031/
智鼠故事 
